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Abstract : Oxidative stress is one cause of atherosclerosis that makes it a lifestyle-
related disease.  Oxidized low-density lipoprotein （OxLDL） was previously found 
to be related to oxidative stress, measured using the diacron-reactive oxygen 
metabolites （d-ROMs） test and showed a negative correlation between biologi-
cal antioxidant potential （BAP） test results and triglycerides （TG）.  In addition, 
large gender differences exist among vascular disorders caused by arteriosclerosis.  
However, such gender differences and their correlation with oxidative stress and 
blood lipids have not been claried.  In this study, gender differences in correla-
tions between oxidative stress and blood lipids as factors in the development of 
atherosclerosis was addressed.  Subjects were 149 individuals who underwent medi-
cal examinations conducted in Ashikaga Teishin Clinic in Tochigi, Japan （98 males 
and 51 females）.  A strong positive correlation was observed between d-ROMs test 
results and OxLDL in men （R＝0.480, P＜ 0.0001）, but no correlation was seen 
in women.  A strong negative correlation between BAP test results and TG was 
also noted in men （R＝-0.571, P＜ 0.0001）, and a moderate negative correlation 
was detected in women （R＝-0.344, P＝0.0133）.  A positive correlation between 
d-ROMs tests and OxLDL was seen in women under 50 years of age （R＝0.399, 
P＝0.0393）, but this correlation was not present in women who were 50 years of 
age or older （R＝-0.00656, P＝0.976）.  Correlations between oxidative stress and 
OxLDL and between antioxidant potential and TG in men were more prominent 
than in women.  This nding suggests that decreasing oxidative stress in the blood 
to prevent atherosclerosis is more important for men.
Key words : oxidative stress, diacron-reactive oxygen metabolites （d-ROMs） test, bio-
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Introduction
　The gender difference in vascular disorders caused by arteriosclerosis is signicant1）, and the 
risk of coronary artery disease is largely related to gender and age.  According to the Framing-
ham Study, the incidence of cardiovascular disease gradually increases with age in men.  How-
ever, it remains extremely low in women under 50 years of age before signicantly increasing 
after menopause.  At 65 years of age or above, the incidence in men and women is similar2）. 
In women, estrogen affects lipid metabolism and lowers low-density lipoprotein （LDL） by 
inhibiting 3-hydroxy-3-methylglutaryl coenzyme A （HMG-CoA） reductase activity3） and enhancing 
LDL receptor expression4）.  Further, estrogen promotes synthesis of apolipoprotein A-I, a major 
constituent of high-density lipoprotein （HDL）, and enhances the production of HDL5）.
　Oxidative stress, an important factor in atherosclerosis, is caused by pathological states such 
as hypertension6）, diabetes7）, and dislipidemia8）.  LDL is changed to oxidized （Ox） LDL by 
oxidative stress in the blood, and OxLDL is thus an important marker for development of 
atherosclerosis8）.  OxLDL is taken up by macrophages via the scavenger receptor, which leads 
to the appearance of foam cells.  These cholesterol-lled macrophages create the initial lesions 
in atherosclerosis9）.  Peroxide in atherosclerotic lesions causes inammation and cytokine release 
from vascular wall cells and macrophages.  Atherosclerosis is caused by the disturbance and 
growth of vascular wall cells and the accumulation of substances such as lipids10）.
　Recently, simple methods for measuring oxidative stress and antioxidant potential, the diacron-
reactive oxygen metabolites （d-ROMs） test and the biological antioxidant potential （BAP） test, 
have become available11）.  The d-ROMs test is a colorimetric determination of hydroperoxide 
levels in the blood caused by reactive oxygen and free radicals and is an all-inclusive measure 
of levels of oxidative stress in vivo11）.  The BAP test measures the ability of reducing agents to 
donate electrons to reactive oxygen and free radicals to stop oxidative reactions11）.  Previously, 
OxLDL was shown to be related to oxidative stress and a negative correlation was shown to 
exist between antioxidant potential and triglycerides （TG）12）.
　Small dense LDL is important, in addition to OxLDL, in atherosclerosis13）.  Small dense 
LDL more easily passes through cell membranes, has lower afnity for the LDL receptor, and 
undergoes slower catabolism than large LDL.  These characteristics give it a primary role in the 
induction of atherosclerosis14）.  The LDL / HDL ratio is an independent predictor of myocardial 
infarction15）.  However, gender differences in the relationship between oxidative stress and blood 
lipids have not been claried.  In this study, gender differences in the correlation between oxida-
tive stress and blood lipids were investigated as a factor in the development of atherosclerosis.
Materials and methods
Study population
　Subjects included 149 individuals who underwent medical examination （April 5, 2006 to June 
30, 2006） conducted in Ashikaga Teishin Clinic in Tochigi, Japan （98 males and 51 females）. 
The mean age of subjects was 44.11±13.7 years （median 43 years : range 20-68 years）.  This 
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study was approved by the Ethics Committee of the Ashikaga Teishin Clinic.  This study pres-
ents new analyses performed using the same subjects as in a previously published paper12）.
Data collection
　Age and glycohemoglobin A1c （HbA1c）, OxLDL, LDL, TG, apolipoprotein B （ApoB）, total 
cholesterol （TC）, and HDL were recorded.  4HNE （hydroxy-nonenal）-LDL was quantied to 
represent OxLDL using ELISA （Mitsubishi Petrochemical, Tokyo）.  For small dense LDL, a 
positive correlation is observed between LDL / ApoB ratio and LDL diameter16）, thus, a negative 
correlation exists between small dense LDL and LDL / ApoB ratio.  Correlations between oxida-
tive stress and LDL / ApoB ratio were generated.  In addition, LDL / HDL ratio and OxLDL /
HDL ratio were assessed as markers for atherosclerosis.
　Blood serum samples were stored at -80℃ until centrifugation to separate serum.  d-ROMs 
tests were performed using N-diethyl-paraphenylenediamine （WISMERLL, Tokyo） as a measure 
of oxidative stress.  BAP tests were performed using FeCl3 to measure antioxidant potential12）.
Statistical analysis
　Subjects were divided by gender and analyzed separately.  Gender groups were subdivided into 
individuals less than 50 years of age and individuals 50 years of age or older.  This subdivision 
reects the cyclical effects of female sex hormones （e.g., estrogen） prior to menopause.  Women 
50 years of age or older are mostly postmenopausal and less affected by female hormones. 
Regression analyses were used to characterize correlations （OriginPro.  Lightstone Co., Tokyo）. 
Comparisons between groups used the Mann-Whitney U test （ystat2013. Xls, Tokyo） and are 
shown as means±standard deviation.  P＜ 0.05 was considered signicant.
Results
　No difference between men and women was observed for LDL （P＝0.801）.  A significant 
difference between men and women in OxLDL was seen （P＝0.041）.  Further, a signicant dif-
ference was found in LDL / HDL （P＝0.038） and OxLDL / HDL （P ＜ 0.001） ratios.  Another 
signicant gender difference was detected in LDL / ApoB ratio as an indicator of small dense LDL 
（P＝0.002）, and in TG （P＝0.002） and HDL （P＜ 0.001）.  No gender difference in d-ROMs test 
（P＝0.776） and BAP test （P＝0.552） results was identied.  However, in d-ROMs test by women, 
a signicant difference was noted between those under 50 and 50 and over （P＝0.010） （Table 1）.
　Correlation between plasma lipids and oxidative stress included a strong positive correlation 
between d-ROMs test results and OxLDL in men （R＝0.480, P＜ 0.001） （Fig. 1A）, but no such 
correlation in women （R＝0.241, P＝0.089） （Fig. 1B）.  Further, a strong positive correlations 
between d-ROMs test results and OxLDL in men under 50 and 50 and over ［（R＝0.435, P＝
0.001） （Fig. 2A） and （R＝0.545, P＜ 0.001） （Fig. 2B）, respectively］.  A weaker positive correla-
tion between d-ROMs test results and OxLDL was found in women under 50 （R＝0.399, P＝
0.039） （Fig. 2C）, and no such correlation was observed in women 50 and over （R＝-0.007, P＝
0.976） （Fig. 2D）.
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Comparisons between groups by gender and by age. Men, n＝98 （median 41.5 years: range 20-65 years）; Women, 
n＝51 （median 47.0 years: range 23-68 years）, those under 50 years of age, n＝84; those 50 years of age or older, 
n＝62; men under 50 years of age, n＝57 （median 31.0 years: range 20-49 years）; men 50 years of age or older, 
n＝41 （median 56.0 years: range 51–65 years）; women under 50 years of age, n＝27 （median 38.5 years: range 23-47 
years）; women 50 years of age or older, n＝24 （median 60.0 years: range 51-68 years）.
Comparisons between groups used the Mann-Whitney U test and means± standard deviation are shown. P＜ 0.05 was 
considered significant.
Table 1.  Comparisons between groups by age and gender
Total Men Women P
Total LDL （mg/dl） 115.0±27.4 117.7±25.9 0.801
Age≤ 50 110.3±25.2 110.2±28.0 110.5±18.6 0.928
Age＞50 123.2±27.6 121.7±25.6 125.8±31.1 0.697
P 0.004 0.045 0.042
Total OxLDL（U/ml）   1.76±0.45  1.63±0.44 0.041
Age≤ 50   1.66±0.46   1.72±0.48  1.55±0.41 0.100
Age＞50   1.78±0.43   1.82±0.40  1.71±0.47 0.314
P 0.035 0.100 0.166
Total LDL/HDL   2.12±0.76  1.82±0.53 0.038
Age≤ 50   1.94±0.74   2.05±0.80  1.70±0.53 0.053
Age＞50   2.13±0.65   2.22±0.72  1.96±0.50 0.308
P 0.036 0.176 0.052
Total OxLDL/HDL 0.033±0.01 0.025±0.01 ＜0.001
Age≤ 50 0.030±0.01 0.032±0.01 0.024±0.01 0.005
Age＞50 0.031±0.01 0.034±0.01 0.027±0.08 0.031
P 0.157 0.348 0.137
Total LDL/ApoB   1.16±0.20  1.26±0.19 0.002
Age≤ 50   1.18±0.18   1.15±0.18  1.25±0.17 0.019
Age＞50   1.21±0.22   1.18±0.22  1.27±0.21 0.033
P 0.127 0.234 0.341
Total TG （mg/dl）   130.6±88.1 93.8±42.5 0.002
Age≤ 50 108.8±61.8   120.4±68.3 84.2±35.1 0.006
Age＞50 130.0±93.8   144.8±110.1 104.7±48.7 0.076
P 0.066 0.241 0.055
Total HDL（mg/dl） 57.6±13.2  66.9±11.5 ＜0.001
Age≤ 50   60.6±12.9 57.2±12.3  67.9±11.7 0.001
Age＞50   61.0±14.2 58.1±14.6  65.8±12.2 0.027
P 0.943 0.850 0.464
Total d-ROMs （U.CARR） 292.9±64.4 301.9±74.1 0.776
Age≤ 50 284.6±69.0 286.6±67.6 280.4±72.9 0.510
Age＞50 301.7±64.9 301.6±60.2 326.1±70.8 0.274
P 0.005 0.114 0.010
Total BAP （µmol/l） 3627.2±341.5 3611.3±281.2 0.552
Age≤ 50 3651.0±303.6 3654.2±319.6 3644.2±272.5 0.600
Age＞50 3584.0±345.8 3589.8±374.6 3574.2±297.7 0.904
P 0.153 0.254 0.391
Total ApoB （mg/dl） 100.1±22.2  94.7±21.5 0.070
Age≤ 50  94.5±21.5  96.5±21.5  90.3±21.1 0.083
Age＞50 103.2±22.2 105.2±22.6  99.7±21.7 0.500
P 0.007 0.079 0.022
Total TC （mg/dl） 198.8±29.4 203.4±28.0 0.451
Age≤ 50 192.7±25.5 191.5±28.8 195.3±16.5 0.480
Age＞50 210.2±30.7 208.8±27.9 212.5±35.6 0.742
P 0.006 0.005 0.045
Total HbA1c （％）  5.33±0.62  5.15±0.44 0.114
Age≤ 50   5.06±0.52  5.12±0.59  4.93±0.29 0.315
Age＞50   5.54±0.51  5.62±0.53  5.40±0.45 0.076
P ＜ 0.001 ＜ 0.001 ＜ 0.001
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Fig. 1.  Correlations between oxidative stress and OxLDL
A： Scatter plot of diacron-reactive oxygen metabolites （d-ROMs） test results and 
oxidized low-density lipoprotein （OxLDL） in men. R＝0.480, P＜ 0.001
B：Scatter plot of d-ROMs test results and OxLDL in women. R＝0.241, P＝0.089
Fig. 2.  Correlations between oxidative stress and OxLDL
A： Scatter plot of diacron-reactive oxygen metabolites （d-ROMs） test results and oxidized low-density 
lipoprotein （OxLDL） in men under 50 years of age. R＝0.435, P＜ 0.001
B：Scatter plot of d-ROMs test results and OxLDL in men 50 years of age or older. R＝0.545, P＜ 0.001
C：Scatter plot of d-ROMs test results and OxLDL in women under 50 years of age. R＝0.399, P＝0.039
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　A strong negative correlation between BAP test results and TG in men （R＝ -0.571, P ＜
0.001） （Fig. 3A）, and a weaker negative correlation in women （R＝-0.344, P＝0.013） （Fig. 3B） 
were observed.  Further, strong negative correlations were found between BAP test results and 
TG in men under 50 and 50 and over years of age ［（R＝-0.613, P＜ 0.001） （Fig. 4A） （R＝  
-0.544, P＜ 0.001） （Fig. 4B）, respectively］.  However, no such correlation was found in women 
under 50 （R＝-0.003, P＝0.987） （Fig. 4C）, but a negative correlation was found for women 50 
and over （R＝-0.572, P＝0.004） （Fig. 4D）.
　Small dense LDL was evaluated using LDL / ApoB ratios.  A negative correlation between 
d-ROMs test results and LDL / ApoB ratio was found in both men （R＝-0.252, P＝0.012） （Fig. 
5A） and women （R＝-0.307, P＝0.028） （Fig. 5B）.  No such correlation was observed in men 
under 50 years of age （R＝-0.126, P＝0.349） （Fig. 6A）.  A negative correlation between d-ROMs 
test results and LDL / ApoB ratio was seen in men 50 years of age or older （R＝–0.444, P＝
0.004） （Fig. 6B）, and was weaker than the correlation between d-ROMs test results and OxLDL.  A 
similar negative correlation was observed in women under 50 years of age （R＝-0.524, P＝0.005） 
（Fig. 6C）, and was stronger than the correlation between d-ROMs test results and OxLDL.  No cor-
relation was observed for women 50 or older （R＝-0.184, P＝0.389） （Fig. 6D）.
　A positive correlation between d-ROMs test results and OxLDL / HDL ratios was found for 
men under 50 and 50 and over years of age, （R＝0.392, P＝0.003 and （R＝0.525, P＜ 0.001, 
respectively）.  A negative correlation between BAP test results and OxLDL / HDL ratio was 
seen in men under 50 （R＝-0.458, P＜ 0.001） （Table 2）.
　No correlations between OxLDL and small dense LDL were observed for men or women （R＝  
-0.002, P＝0.988 and＝0.160, P＝0.263, respectively）, in men or women under 50 （R＝0.163, 
P＝0.225 and R＝0.101, P＝0.616, respectively） or in men or women 50 and over （R＝–0.239, 





Fig. 3.  Correlations between antioxidant potential and TG
A： Scatter plot of biological antioxidant potential （BAP） test results and triglycerides 
（TG） in men. R＝-0.571, P＜ 0.001
B：Scatter plot of BAP test results and TG in women. R＝-0.344, P＝0.013
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Fig. 4.  Correlations between antioxidant potential and TG
A： Scatter plot of biological antioxidant potential （BAP） test results and triglycerides （TG） in 
men under 50 years of age. R＝-0.613, P＜ 0.001
B：Scatter plot of BAP test results and TG in men 50 years of age or older. R＝-0.544, P＜ 0.001
C：Scatter plot of BAP test results and TG in women under 50 years of age. R＝-0.00329, P＝0.987
D：Scatter plot of BAP test results and TG in women 50 years of age or older. R＝-0.572, P＝0.004
Fig. 5.  Correlations between oxidative stress and LDL / ApoB ratio
A： Scatter plot of diacron-reactive oxygen metabolites （d-ROMs） test results and LDL / ApoB 
ratio in men. R＝-0.254, P＝0.012
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Fig. 6.  Correlations between oxidative stress and LDL / ApoB ratio
A： Scatter plot of diacron-reactive oxygen metabolites （d-ROMs） test results and LDL / ApoB 
ratio in men under 50 years of age. R＝-0.126, P＝ 0.349
B： Scatter plot of d-ROMs test results and LDL / ApoB ratio in men 50 years of age or older. 
R＝-0.444, P＝0.004
C： Scatter plot of d-ROMs test results and LDL / ApoB ratio in women under 50 years of age. 
R＝-0.524, P＝0.005
D： Scatter plot of d-ROMs test results and LDL / ApoB ratio in women 50 years of age or 
older. R＝-0.184, P＝ 0.389
Table 2.  Correlations between oxidative stress and OxLDL / HDL 
d-ROMs and OxLDL / HDL BAP and OxLDL / HDL
Men
　Total R＝ 0.443，P＜0.001 R＝-0.336，P＜0.001
　Age ≤ 50 R＝ 0.392，P＜0.001 R＝-0.458，P＜0.001
　Age＞ 50 R＝ 0.525，P＜0.001 R＝-0.177，P＝ 0.270
Women
　Total R＝ 0.375，P＝ 0.007 R＝   0.025，P＝ 0.860
　Age ≤ 50 R＝ 0.472，P＝ 0.013 R＝   0.226，P＝ 0.258
　Age＞ 50 R＝ 0.189，P＝ 0.377 R＝-0.166，P＝ 0.437
Correlations between oxidative stress and OxLDL / HDL ratio in men and 
women and in age groups under 50 years of age and 50 years of age or 
older.
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Discussion
　Recently, coronary risk assessment for factors such as gender, age, smoking, serum cholesterol, 
and systolic blood pressure have been used to manage target values of dyslipidemia17）.  Accord-
ing to NIPPON DATA80, mortality from ischemic heart disease is extremely low for women 
under 50 years of age （＜0.5％）1）.  In this study, signicant differences between men and women 
in OxLDL, LDL / ApoB ratio, OxLDL / HDL ratio, LDL / HDL ratio, TG, and HDL were found. 
Estrogen increases nitric oxide production in endothelial cells and inhibits proliferation of vessel 
wall cells18）.  No difference between men and women were observed in LDL and d-ROMs test 
results, but a signicant difference was seen with OxLDL.  Possibly, when estrogen is suppressed 
in women, LDL is oxidized to LDL by oxidative stress.  No difference in LDL between men 
and women was seen, but a signicant difference in LDL / ApoB ratios as an indicator of small 
dense LDL was seen.  Estrogen may suppress the change of LDL to small dense LDL, which 
more effectively induces atherosclerosis14）.
　In this study, a strong positive correlation was found between d-ROMs test results and 
OxLDL in men, but no correlation was observed in women.  Also, a negative correlation was 
seen between BAP test results and TG in both men and women, but it was stronger in men. 
Likewise, a similar correlation was seen between d-ROMs test results and small dense LDL in 
both men and women, indicating that small dense LDL, as well as OxLDL, are markers of oxi-
dative stress.  The correlation between OxLDL and small dense LDL in men was stronger than 
that in women.  A positive correlation between oxidative stress and OxLDL / HDL was also 
observed in both men and women, and the correlation was stronger in women.
　Correlation analysis between oxidative stress and lipids in plasma was positive for d-ROMs 
test results and OxLDL in women under 50 years of age, but the correlation was weaker than 
the correlation between d-ROMs test results and small dense LDL.  In men, the opposite was 
found, where the OxLDL, d-ROMs test correlation was stronger.  These results suggest that 
estrogen can suppress the oxidation of small dense LDL to OxLDL.
　In women 50 years of age or older, no correlations were observed between OxLDL or small 
dense LDL and d-ROMs test results.  In women, a positive correlation was found for d-ROMs 
test results with age, but no correlation with OxLDL.  In women, factors other than estrogen 
were involved in the change of LDL to OxLDL by oxidative stress.
Table 3.  Correlations between OxLDL and LDL / ApoB ratio
Men Women
Total R＝-0.002，P＝ 0.988 R＝ 0.160，P＝ 0.263
Age ≤ 50 R＝   0.163，P＝ 0.225 R＝ 0.101，P＝ 0.616
Age＞ 50 R＝-0.239，P＝ 0.133 R＝ 0.188，P＝ 0.378
Correlations between OxLDL and the LDL / ApoB ratio in men 
and women, and in age groups under 50 years of age and 50 
years of age or older.
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　Recently, an increase in smoking rates among young Japanese women has been reported19）. 
After smoking, substances present in tobacco are absorbed into the bloodstream and oxidize 
LDL, thus promoting the progression of atherosclerosis20）.  However, coronary artery mortality 
in women under 50 years of age is less than 0.5％ regardless of smoking behavior1）.  Possibly, 
smoking promotes the progression of atherosclerosis in women under 50 years of age, but in 
women 50 years of age or older, no correlation between oxidative stress and OxLDL was seen, 
even after menopause.  Further, exercise is increasing among the elderly21）, and moderate exer-
cise is effective in preventing oxidative stress22）.  Possibly, increased exercise also helps retard the 
progression of atherosclerosis after menopause.
　Correlations among d-ROMs test results and small dense LDL and OxLDL / HDL ratios in 
men 50 years of age and OxLDL was similar in the two age groups.  Many men 50 years of 
age or older with lifestyle-related diseases receive treatment.  The occurrence of oxidative stress 
may be prevented or reduced by treatment for diabetes23）, hypertension24）, and dyslipidemia25）. 
Such treatment could affect correlations between d-ROMs test results and OxLDL.
　No correlation is observed between BAP test results and TG in women under 50 years of 
age, and a negative correlation is found in women 50 or over.  Estrogen inhibits fat accumula-
tion by controlling the activity and expression of lipoprotein lipase26）, and in women under 50, 
study results suggest that estrogen suppresses the increase in TG even when antioxidant potential 
is low.  A negative correlation between BAP tests and TG in women 50 years and older exists 
and it is possible that antioxidant potential measurements will help postmenopausal women alter 
their diet to improve TG levels.  In study subjects, medication and dietary supplement use for 
lifestyle-related illnesses were unknown, and it is possible that drugs and supplements might have 
affected outcomes.
　Effects of statin therapy differ between men and women27，28）, and the present study may pro-
vide an explanation.  Correlations between oxidative stress and OxLDL and between antioxidant 
potential and TG in men were stronger than those in women.  For correlations between lipids 
and oxidative stress, estrogen may affect oxidation of LDL to OxLDL or to small dense LDL. 
For men, decreasing oxidative stress in the blood may be more important than for women to 
prevent atherosclerosis.
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